Sanofi completes the acquisition of Vigil Neuroscience, Inc.Paris, August 6, 2025. Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. ('Vigil”). This acquisition ...

Sanofi Consumer Healthcare said its growth was driven by successful product launches and the successful relaunch of two ...

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

Sanofi Consumer Healthcare India surged 12.56% to Rs 5385 after the company announced strong financial results for the second quarter of 2025.

The health department ends 22 federal investments as data showed they fail to protect against Covid and flu infections effectively.

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and ...

The United States Department of Health and Human Services said yesterday it would wind down mRNA vaccine development activities under its biomedical research unit.

Converging evidence supports a key pathogenic role of the glymphatic system in the accumulation of pathological aggregates in ...

The UK’s National Health Service (NHS) and local authorities have started the rollout of world-first gonorrhoea vaccination ...

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business ...